drugset / Trial / NCT06606860
Safety, Tolerability and PK of Single and Multiple Doses of Oxantel Pamoate Tablets
Phase 1
Completed
45 enrolled
Swiss Tropical & Public Health Institute
Drugs for Neglected Diseases initiative · collabIfakara Health Institute · collab
RandomizedParallel-groupTriple-blindTreatment
Summary
The goal of this clinical trial is to evaluate the safety, tolerability and pharmacokinetics of oxantel pamoate tablet after administration of a single and multiple dose in healthy male and female adult volunteers. The main questions aim to answer if oxantel pamoate is safe and well tolerated in healthy volunteers and if is it absorbed by the human body. A single dose and a multiple dose of oxantel pamoate will be compared to placebo to see if there are any different effects.
Timeline
- Start
- 2025-01-27
- Primary completion
- 2025-04-08
- Completion
- 2025-04-08
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Oxantel Pamoate | Unknown | 20 mg/kg | Oral |
Indications
No indication recorded.